Contact
searchSearch
HMP Global

Podcasts

Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
05/11/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/11/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/10/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/10/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
04/30/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
04/30/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
04/23/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
04/23/2026
Rheumatology & Arthritis
Expert Insights
Daniel Solomon, MD, on Treat to Target vs Symptoms in Gout
02/04/2026
Daniel Hal Solomon, MD
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon...
02/04/2026
Rheumatology & Arthritis
Dacre Knight
Podcast
Dacre Knight, MD, on Hypermobility
04/30/2025
Dacre Knight, MD
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo...
04/30/2025
Rheumatology & Arthritis
Len Calabrese
Podcast
Leonard Calabrese, DO, on Long COVID Similarities to Fibromyalgia, ME/CFS
01/02/2025
Leonard Calabrese, DO
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the...
01/02/2025
Rheumatology & Arthritis
Misti Paudel
Podcast
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck...
06/20/2024
Rheumatology & Arthritis

Popular Articles

News
NSAID Dose Associated With Risk of CVD Among Patients With axSpA
07/16/2024
Rebecca Mashaw
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Korean researchers found that...
07/16/2024
Rheumatology & Arthritis
Quiz
NSAIDs and axSpA
08/30/2024
Riya Gandhi, MA
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between...
08/30/2024
Rheumatology & Arthritis
News
Sex, Age Differences Affect Interstitial Lung Disease Subtypes in Rheumatoid Arthritis
10/18/2024
Jessica Garlewicz
Researchers aimed to explore risk factors associated with usual interstitial pneumonia and nonspecific interstitial pneumonia.
Researchers aimed to explore risk factors associated with usual interstitial pneumonia and nonspecific interstitial pneumonia.
Researchers aimed to explore...
10/18/2024
Rheumatology & Arthritis
News
Disease Activity, Physical Function Associated With Worse Quality of Life in axSpA
08/06/2024
Rebecca Mashaw
Clinical and sociodemographic characteristics are critical in quality of life and functioning, researchers reported.
Clinical and sociodemographic characteristics are critical in quality of life and functioning, researchers reported.
Clinical and sociodemographic...
08/06/2024
Rheumatology & Arthritis
News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
08/28/2024
Jolynn Tumolo
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
08/28/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use